Page last updated: 2024-10-26

diclofenac and Spondylitis, Ankylosing

diclofenac has been researched along with Spondylitis, Ankylosing in 44 studies

Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.

Spondylitis, Ankylosing: A chronic inflammatory condition affecting the axial joints, such as the SACROILIAC JOINT and other intervertebral or costovertebral joints. It occurs predominantly in young males and is characterized by pain and stiffness of joints (ANKYLOSIS) with inflammation at tendon insertions.

Research Excerpts

ExcerptRelevanceReference
" It has proved as effective as diclofenac, naproxen and piroxicam in patients with osteoarthritis, diclofenac, ketorolac, tenoxicam and indomethacin in patients with rheumatoid arthritis and tenoxicam, naproxen and indomethacin in patients with ankylosing spondylitis."8.82Aceclofenac in the management of inflammatory pain. ( Legrand, E, 2004)
"The aim of this article is to critically review the potential role of aceclofenac in the treatment of inflammatory pain and chronic osteoarticular disorder, based on its activity on the mediators of inflammation, its effect on cartilage remodeling and on the results of clinical studies comparing aceclofenac with other NSAIDs in these disorders."8.81[What is the role of aceclofenac in the therapeutic arsenal against chronic osteoarthritis pathologies?]. ( Henrotin, Y; Paul, I; Reginster, JY, 2001)
" Published data indicate that diclofenac 75 to 150mg daily (25 to 50mg 3 times daily) is comparable in efficacy with ordinary aspirin 3 to 5g daily and indomethacin 75 to 150mg daily in rheumatoid arthritis and with indomethacin in osteoarthritis."8.76Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin. ( Avery, GS; Brogden, RN; Heel, RC; Pakes, GE; Speight, TM, 1980)
"Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) advocated for use in painful and inflammatory rheumatic and certain non-rheumatic conditions."6.16Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. ( Sorkin, EM; Todd, PA, 1988)
" It has proved as effective as diclofenac, naproxen and piroxicam in patients with osteoarthritis, diclofenac, ketorolac, tenoxicam and indomethacin in patients with rheumatoid arthritis and tenoxicam, naproxen and indomethacin in patients with ankylosing spondylitis."4.82Aceclofenac in the management of inflammatory pain. ( Legrand, E, 2004)
"The aim of this article is to critically review the potential role of aceclofenac in the treatment of inflammatory pain and chronic osteoarticular disorder, based on its activity on the mediators of inflammation, its effect on cartilage remodeling and on the results of clinical studies comparing aceclofenac with other NSAIDs in these disorders."4.81[What is the role of aceclofenac in the therapeutic arsenal against chronic osteoarthritis pathologies?]. ( Henrotin, Y; Paul, I; Reginster, JY, 2001)
" Published data indicate that diclofenac 75 to 150mg daily (25 to 50mg 3 times daily) is comparable in efficacy with ordinary aspirin 3 to 5g daily and indomethacin 75 to 150mg daily in rheumatoid arthritis and with indomethacin in osteoarthritis."4.76Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin. ( Avery, GS; Brogden, RN; Heel, RC; Pakes, GE; Speight, TM, 1980)
" In both groups, the most frequently reported adverse events were gastrointestinal in nature, with abdominal pain reported most frequently (in 22."3.77Review of the safety of diclofenac/misoprostol. ( Gagnier, P, 1993)
"To perform a modelled economic analysis of the efficacy and tolerability of aceclofenac in comparison with those of other nonsteroidal antiinflammatory drugs (NSAIDs) used in the treatment of common arthritic disorders including osteoarthritis, rheumatoid arthritis and ankylosing spondylitis."3.71Iatrogenic cost factors incorporating mild and moderate adverse events in the economic comparison of aceclofenac and other NSAIDs. ( Badia, X; Brosa, M; Martínez, E; Peris, F, 2001)
"Both celecoxib treatment groups were non-inferior to diclofenac."2.82Celecoxib versus diclofenac for the treatment of ankylosing spondylitis: 12-week randomized study in Norwegian patients. ( Essex, MN; Li, C; Park, PW; Walker, C, 2016)
"Active disease was defined by Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for more than 3 at randomization."2.78Tramadol/acetaminophen combination as add-on therapy in the treatment of patients with ankylosing spondylitis. ( Chang, IC; Chang, JK; Lee, MY; Tsou, HK; Wei, JC; Yeo, K; Yu, CT, 2013)
" Forty-two adverse events possibly or probably related to treatment were observed in the aceclofenac group and 37 in the tenoxicam group."2.68Aceclofenac is as safe and effective as tenoxicam in the treatment of ankylosing spondylitis: a 3 month multicenter comparative trial. Spanish Study Group on Aceclofenac in Ankylosing Spondylitis. ( de Buergo, M; Montull Fruitós, E; Rico Lenza, H; Villa Alcázar, LF, 1996)
" Patients were then randomised to receive a diclofenac 50mg/misoprostol 200 micrograms fixed combination tablet (n = 331) or diclofenac 50mg (n = 339) for 8 weeks at the same dosage frequency as in the open-label phase."2.67Efficacy of diclofenac/misoprostol vs diclofenac in the treatment of ankylosing spondylitis. ( McKenna, F, 1993)
"Ankylosing spondylitis is a systemic rheumatic disorder characterized by inflammation of the spine, sacroiliac, and large peripheral joints."2.66Efficacy of diclofenac in ankylosing spondylitis. ( Calabro, JJ, 1986)
" Traditional NSAIDs are associated with an increased risk of serious gastrointestinal (GI) adverse events versus COX-2 selective inhibitors, and chronic use frequently necessitates adjunctive therapy with gastroprotective agents."2.44Efficacy of the newest COX-2 selective inhibitors in rheumatic disease. ( Baraf, HS, 2007)
"When Whipple's disease was diagnosed this treatment was stopped and antibiotics (ceftriaxone) was started and then continued with co-trimoxazole for one year with significantly improvement in her condition."1.35[Whipple's disease with normal duodenal histology and ankylosing spondylitis]. ( Ahmadi-Simab, K; Schnitzler, P, 2009)
"Drug studies in ankylosing spondylitis (AS) are usually short term, in highly selected patients at academic centers."1.28A prospective nationwide cross-sectional study of NSAID usage in 1331 patients with ankylosing spondylitis. ( Calin, A; Elswood, J, 1990)

Research

Studies (44)

TimeframeStudies, this research(%)All Research%
pre-199012 (27.27)18.7374
1990's12 (27.27)18.2507
2000's13 (29.55)29.6817
2010's7 (15.91)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kopylov, AT1
Novikov, AA1
Kaysheva, AL1
Vykhodets, IT1
Karateev, DE1
Zgoda, VG1
Lisitsa, AV1
Winiczenko, R1
Górnicki, K1
Kaleta, A1
Janaszek-Mańkowska, M1
Khan, ZA1
Singh, C1
Khan, T1
Ganguly, M1
Bradsher, C1
Goodwin, P1
Petty, JT1
Sandau, C1
Bove, DG1
Marsaa, K1
Bekkelund, CS1
Lindholm, MG1
Salazar, J1
Bermúdez, V1
Olivar, LC1
Torres, W1
Palmar, J1
Añez, R1
Ordoñez, MG1
Rivas, JR1
Martínez, MS1
Hernández, JD1
Graterol, M1
Rojas, J1
Mubarak, Z1
Humaira, A1
Gani, BA1
Muchlisin, ZA1
Gremillet, C1
Jakobsson, JG1
Gomila, A1
Shaw, E1
Carratalà, J1
Leibovici, L1
Tebé, C1
Wiegand, I1
Vallejo-Torres, L1
Vigo, JM1
Morris, S1
Stoddart, M1
Grier, S1
Vank, C1
Cuperus, N1
Van den Heuvel, L1
Eliakim-Raz, N1
Vuong, C1
MacGowan, A1
Addy, I1
Pujol, M1
Cobb, A1
Rieger, E1
Bell, J1
Mallik, S1
Zhao, Z1
Szécsényi, Á1
Li, G1
Gascon, J1
Pidko, EA1
Zhang, GR1
Wolker, T1
Sandbeck, DJS1
Munoz, M1
Mayrhofer, KJJ1
Cherevko, S1
Etzold, BJM1
Lukashuk, L1
Yigit, N1
Rameshan, R1
Kolar, E1
Teschner, D1
Hävecker, M1
Knop-Gericke, A1
Schlögl, R1
Föttinger, K1
Rupprechter, G1
Franconieri, F1
Deshayes, S1
de Boysson, H1
Trad, S1
Martin Silva, N1
Terrier, B1
Bienvenu, B1
Galateau-Sallé, F1
Emile, JF1
Johnson, AC1
Aouba, A1
Vogt, TJ1
Gevensleben, H1
Dietrich, J1
Kristiansen, G1
Bootz, F1
Landsberg, J1
Goltz, D1
Dietrich, D1
Idorn, M1
Skadborg, SK1
Kellermann, L1
Halldórsdóttir, HR1
Holmen Olofsson, G1
Met, Ö1
Thor Straten, P1
Johnson, LE1
Brockstedt, D1
Leong, M1
Lauer, P1
Theisen, E1
Sauer, JD1
McNeel, DG1
Morandi, F1
Marimpietri, D1
Horenstein, AL1
Bolzoni, M1
Toscani, D1
Costa, F1
Castella, B1
Faini, AC1
Massaia, M1
Pistoia, V1
Giuliani, N1
Malavasi, F1
Qiu, J1
Peng, S1
Yang, A1
Ma, Y1
Han, L1
Cheng, MA1
Farmer, E1
Hung, CF1
Wu, TC1
Modak, S1
Le Luduec, JB1
Cheung, IY1
Goldman, DA1
Ostrovnaya, I1
Doubrovina, E1
Basu, E1
Kushner, BH1
Kramer, K1
Roberts, SS1
O'Reilly, RJ1
Cheung, NV1
Hsu, KC1
Salgarello, T1
Giudiceandrea, A1
Calandriello, L1
Marangoni, D1
Colotto, A1
Caporossi, A1
Falsini, B1
Lefrançois, P1
Xie, P1
Wang, L2
Tetzlaff, MT1
Moreau, L1
Watters, AK1
Netchiporouk, E1
Provost, N1
Gilbert, M1
Ni, X1
Sasseville, D1
Wheeler, DA1
Duvic, M1
Litvinov, IV1
O'Connor, BJ1
Fryda, NJ1
Ranglack, DH1
Yang, Y2
Yang, J1
Zhang, X2
Grün, AL1
Emmerling, C1
Aumeeruddy-Elalfi, Z1
Ismaël, IS1
Hosenally, M1
Zengin, G1
Mahomoodally, MF1
Dotsenko, A1
Gusakov, A1
Rozhkova, A1
Sinitsyna, O1
Shashkov, I1
Sinitsyn, A1
Hong, CE1
Kim, JU1
Lee, JW1
Lee, SW1
Jo, IH1
Pandiyarajan, S1
Premasudha, P1
Kadirvelu, K1
Wang, B1
Luo, L1
Wang, D1
Ding, R1
Hong, J1
Caviezel, D1
Maissen, S1
Niess, JH1
Kiss, C1
Hruz, P1
Pockes, S1
Wifling, D1
Keller, M1
Buschauer, A1
Elz, S1
Santos, AF1
Ferreira, IP1
Pinheiro, CB1
Santos, VG1
Lopes, MTP1
Teixeira, LR1
Rocha, WR1
Rodrigues, GLS1
Beraldo, H1
Lohar, S1
Dhara, K1
Roy, P1
Sinha Babu, SP1
Chattopadhyay, P1
Sukwong, P1
Sunwoo, IY1
Lee, MJ1
Ra, CH1
Jeong, GT1
Kim, SK2
Huvinen, E1
Eriksson, JG1
Stach-Lempinen, B1
Tiitinen, A1
Koivusalo, SB1
Malhotra, M1
Suresh, S1
Garg, A1
Wei, L1
Jiang, Y2
Zhou, W1
Liu, S1
Liu, Y1
Rausch-Fan, X1
Liu, Z1
Marques, WL1
van der Woude, LN1
Luttik, MAH1
van den Broek, M1
Nijenhuis, JM1
Pronk, JT1
van Maris, AJA1
Mans, R1
Gombert, AK1
Xu, A1
Sun, J1
Li, J1
Chen, W2
Zheng, R1
Han, Z1
Ji, L1
Shen, WQ1
Bao, LP1
Hu, SF1
Gao, XJ1
Xie, YP1
Gao, XF1
Huang, WH1
Lu, X1
Gostin, PF1
Addison, O1
Morrell, AP1
Zhang, Y2
Cook, AJMC1
Liens, A1
Stoica, M1
Ignatyev, K1
Street, SR1
Wu, J1
Chiu, YL1
Davenport, AJ1
Qiu, Z1
Shu, J1
Tang, D1
Gao, X1
Zhang, J3
Huang, K1
Wai, H1
Du, K1
Anesini, J1
Kim, WS1
Eastman, A1
Micalizio, GC1
Liang, JH1
Huo, XK1
Cheng, ZB1
Sun, CP1
Zhao, JC1
Kang, XH1
Zhang, TY1
Chen, ZJ1
Yang, TM1
Wu, YY1
Deng, XP1
Zhang, YX1
Salem, HF1
Kharshoum, RM1
Abou-Taleb, HA1
AbouTaleb, HA1
AbouElhassan, KM1
Ohata, C1
Ohyama, B1
Kuwahara, F1
Katayama, E1
Nakama, T1
Kobayashi, S1
Kashiwagi, T1
Kimura, J1
Lin, JD1
Liou, MJ1
Hsu, HL1
Leong, KK1
Chen, YT1
Wang, YR1
Hung, WS1
Lee, HY1
Tsai, HJ1
Tseng, CP1
Alten, B1
Yesiltepe, M1
Bayraktar, E1
Tas, ST1
Gocmen, AY1
Kursungoz, C1
Martinez, A1
Sara, Y1
Huang, S2
Adams, E1
Van Schepdael, A1
Wang, Q1
Chung, CY1
Yang, W1
Yang, G1
Chough, S1
Chen, Y1
Yin, B1
Bhattacharya, R1
Hu, Y1
Saeui, CT1
Yarema, KJ1
Betenbaugh, MJ1
Zhang, H1
Patik, JC1
Tucker, WJ1
Curtis, BM1
Nelson, MD1
Nasirian, A1
Park, S1
Brothers, RM1
Dohlmann, TL1
Hindsø, M1
Dela, F1
Helge, JW1
Larsen, S1
Gayani, B1
Dilhari, A1
Wijesinghe, GK1
Kumarage, S1
Abayaweera, G1
Samarakoon, SR1
Perera, IC1
Kottegoda, N1
Weerasekera, MM1
Nardi, MV1
Timpel, M1
Ligorio, G1
Zorn Morales, N1
Chiappini, A1
Toccoli, T1
Verucchi, R1
Ceccato, R1
Pasquali, L1
List-Kratochvil, EJW1
Quaranta, A1
Dirè, S1
Heo, K1
Jo, SH1
Shim, J1
Kang, DH1
Kim, JH1
Park, JH1
Akhtar, N1
Saha, A1
Kumar, V1
Pradhan, N1
Panda, S1
Morla, S1
Kumar, S1
Manna, D1
Wang, H1
Xu, E1
Yu, S1
Li, D2
Quan, J1
Xu, L1
Saslow, SA1
Um, W1
Pearce, CI1
Bowden, ME1
Engelhard, MH1
Lukens, WL1
Kim, DS1
Schweiger, MJ1
Kruger, AA1
Adair, LS1
Kuzawa, C1
McDade, T1
Carba, DB1
Borja, JB1
Liang, X2
Song, W1
Wang, K1
Zhang, B1
Peele, ME1
Luo, HR1
Chen, ZY1
Fei, JJ1
Du, ZJ1
Yi, KJ1
Im, WT1
Kim, DW1
Ji, X1
Zhang, C1
Xu, Z1
Ding, Y1
Song, Q1
Li, B2
Zhao, H1
Lee, DW1
Lee, H1
Kwon, BO1
Khim, JS1
Yim, UH1
Park, H1
Park, B1
Choi, IG1
Kim, BS1
Kim, JJ1
Wang, JJ1
Chen, Q1
Li, YZ1
Sakai, M1
Yamaguchi, M1
Nagao, Y1
Kawachi, N1
Kikuchi, M1
Torikai, K1
Kamiya, T1
Takeda, S1
Watanabe, S1
Takahashi, T1
Arakawa, K1
Nakano, T1
Rufo, S1
Continentino, MA1
Nikolaou, V1
Plass, F1
Planchat, A1
Charisiadis, A1
Charalambidis, G1
Angaridis, PA1
Kahnt, A1
Odobel, F1
Coutsolelos, AG1
Fuentes, I1
García-Mendiola, T1
Sato, S1
Pita, M1
Nakamura, H1
Lorenzo, E1
Teixidor, F1
Marques, F1
Viñas, C1
Liu, F1
Qi, P1
Zhang, L1
Sieper, J2
Listing, J1
Poddubnyy, D1
Song, IH1
Hermann, KG1
Callhoff, J1
Syrbe, U1
Braun, J2
Rudwaleit, M2
Walker, C1
Essex, MN1
Li, C1
Park, PW1
Ahmadi-Simab, K1
Schnitzler, P1
Akar, S1
Birlik, M1
Sari, I1
Onen, F1
Akkoc, N1
Jansen, JP1
Gaugris, S1
Choy, EH1
Ostor, A1
Nash, JT1
Stam, W1
Santra, G1
Sarkar, RN1
Phaujdar, S1
Banerjee, S1
Siddhanta, S1
Chang, JK1
Yu, CT1
Lee, MY1
Yeo, K1
Chang, IC1
Tsou, HK1
Wei, JC1
Shi, W1
Wang, YM1
Li, SL1
Yan, M1
Chen, BY1
Cheng, NN1
Legrand, E1
Zochling, J1
Bohl-Bühler, MH1
Baraliakos, X1
Feldtkeller, E1
Rüster, M1
Kiehntopf, M1
Gröne, HJ1
Wolf, G1
Tubach, F1
Pham, T1
Skomsvoll, JF1
Mikkelsen, K1
Bjørneboe, O1
Ravaud, P1
Dougados, M1
Kvien, TK1
Klopsch, T1
Richter, M1
Kapelle, A1
Schwank, S1
Regourd, E1
May, M1
Baraf, HS1
Al-Sharkawi, MS1
Brogden, RN1
Heel, RC1
Pakes, GE1
Speight, TM1
Avery, GS1
Nahir, AM1
Scharf, Y1
Burdeĭnyĭ, AP2
Droste, U1
Siemens, P1
Gargot, D1
Chaussade, S1
d'Alteroche, L1
Desbazeille, F1
Grandjouan, S1
Louvel, A1
Douvin, J1
Causse, X1
Festin, D1
Chapuis, Y1
McKenna, F1
Gagnier, P1
Batlle-Gualda, E1
Figueroa, M1
Ivorra, J1
Raber, A1
Villa Alcázar, LF1
de Buergo, M1
Rico Lenza, H1
Montull Fruitós, E1
Rau, R1
Schwartzenberg, JM1
Smith, DD1
Lindsley, HB1
Ruof, J2
Sangha, O2
Stucki, G2
Reginster, JY1
Paul, I1
Henrotin, Y1
Peris, F1
Martínez, E1
Badia, X1
Brosa, M1
Ozgocmen, S1
Ardicoglu, A1
Kocakoc, E1
Kiris, A1
Ardicoglu, O1
Manz, G1
Franke, M1
Heuft, HG1
Postels, H1
Hoppe, I1
Weisbach, V1
Zeiler, T1
Zingsem, J1
Eckstein, R1
Calin, A1
Elswood, J1
Schwarzer, AC1
Cohen, M1
Arnold, MH1
Kelly, D1
McNaught, P1
Brooks, PM1
Llorca, G1
Larbre, JP1
Collet, P1
Ravault, A1
Lejeune, E1
Todd, PA1
Sorkin, EM1
Calabro, JJ1
Khan, MA2

Clinical Trials (4)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
"Evaluation of Pharmacokinetic Parameters of Diprospan"[NCT03119454]40 participants (Actual)Observational [Patient Registry]2016-10-31Completed
Effects of NSAIDs on RAdiographic Damage in Ankylosing Spondylitis (ENRADAS) - a Prospective Randomised Controlled Trial[NCT00715091]Phase 4180 participants (Actual)Interventional2008-09-30Completed
A Single Center, Randomized, Double-blind, Placebo-controlled 2-way Crossover Study to Investigate the Mechanism of Action of Etoricoxib in Subjects With Osteoarthritis Knee Pain.[NCT01619150]Phase 239 participants (Actual)Interventional2012-07-31Completed
External Validation of a Clinical Scoring System to Predict Microscopic Colitis in Patients With Chronic Watery Diarrhoea[NCT06031064]200 participants (Anticipated)Observational2022-05-15Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

8 reviews available for diclofenac and Spondylitis, Ankylosing

ArticleYear
Aceclofenac in the management of inflammatory pain.
    Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:6

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Clinical Trials as Topic; Diclofenac

2004
Efficacy of the newest COX-2 selective inhibitors in rheumatic disease.
    Current pharmaceutical design, 2007, Volume: 13, Issue:22

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Arthritis, Rheumatoid; Cardiovascular Dis

2007
Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin.
    Drugs, 1980, Volume: 20, Issue:1

    Topics: Adult; Animals; Arthritis, Rheumatoid; Aspirin; Cyclooxygenase Inhibitors; Diclofenac; Drug Interact

1980
Nonsteroidal anti-inflammatory drug-induced colonic strictures: two cases and literature review.
    The American journal of gastroenterology, 1995, Volume: 90, Issue:11

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Colonic Diseases; Colonoscopy; Con

1995
Review of the safety of diclofenac/misoprostol.
    Drugs, 1993, Volume: 45 Suppl 1

    Topics: Arthritis, Rheumatoid; Diclofenac; Drug Combinations; Humans; Misoprostol; Osteoarthritis; Safety; S

1993
[What is the role of aceclofenac in the therapeutic arsenal against chronic osteoarthritis pathologies?].
    Revue medicale de Liege, 2001, Volume: 56, Issue:7

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cartilage; Chronic Disease; Diclofen

2001
[Drug therapy of ankylosing spondyloarthritis (Bechterew's disease)].
    Terapevticheskii arkhiv, 1978, Volume: 50, Issue:12

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Apazone; Butadienes; Cyclophosphamide; Diclofenac

1978
Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Drugs, 1988, Volume: 35, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Clinical Trials as Topic; Diclofenac; D

1988

Trials

21 trials available for diclofenac and Spondylitis, Ankylosing

ArticleYear
Quantitative assessment of betamethasone dual-acting formulation in urine of patients with rheumatoid arthritis and ankylosing spondylitis after single-dose intramuscular administration and its application to long-term pharmacokinetic study.
    Journal of pharmaceutical and biomedical analysis, 2018, Feb-05, Volume: 149

    Topics: Adult; Arthritis, Rheumatoid; Betamethasone; Diclofenac; Drug Combinations; Ethanol; Female; Glucoco

2018
    Neural computing & applications, 2018, Volume: 30, Issue:6

    Topics: Activities of Daily Living; Acute Disease; Adalimumab; Adaptation, Physiological; Adenosine Triphosp

2018
Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a randomised multicentre trial (ENRADAS).
    Annals of the rheumatic diseases, 2016, Volume: 75, Issue:8

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Disease Progression; Drug Administration

2016
Celecoxib versus diclofenac for the treatment of ankylosing spondylitis: 12-week randomized study in Norwegian patients.
    The Journal of international medical research, 2016, Volume: 44, Issue:3

    Topics: Celecoxib; Diclofenac; Endpoint Determination; Humans; Norway; Spondylitis, Ankylosing; Treatment Ou

2016
Tramadol/acetaminophen combination as add-on therapy in the treatment of patients with ankylosing spondylitis.
    Clinical rheumatology, 2013, Volume: 32, Issue:3

    Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Inflammatory Agents, Non-St

2013
Stability of the patient acceptable symptomatic state over time in outcome criteria in ankylosing spondylitis.
    Arthritis and rheumatism, 2006, Dec-15, Volume: 55, Issue:6

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Diclofenac; Female; Follow-Up Studies; He

2006
Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study.
    Annals of the rheumatic diseases, 2008, Volume: 67, Issue:3

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase Inhibito

2008
A multicentre study of diclofenac sodium slow-release (Voltaren Retard) in the treatment of rheumatic disorders in the Kingdom of Saudi Arabia.
    The Journal of international medical research, 1984, Volume: 12, Issue:4

    Topics: Adult; Arthritis, Rheumatoid; Clinical Trials as Topic; Delayed-Action Preparations; Diclofenac; Fem

1984
A comparative study of diclofenac and sulindac in ankylosing spondylitis.
    Rheumatology and rehabilitation, 1980, Volume: 19, Issue:3

    Topics: Adult; Clinical Trials as Topic; Diclofenac; Female; Humans; Indenes; Male; Middle Aged; Phenylaceta

1980
[Double-blind trial of the therapeutic efficacy of voltaren and indomethacin in Bechterew's disease].
    Terapevticheskii arkhiv, 1981, Volume: 53, Issue:7

    Topics: Adult; Clinical Trials as Topic; Dermatitis, Atopic; Diclofenac; Dizziness; Double-Blind Method; Fem

1981
Efficacy of diclofenac/misoprostol vs diclofenac in the treatment of ankylosing spondylitis.
    Drugs, 1993, Volume: 45 Suppl 1

    Topics: Adolescent; Adult; Aged; Diclofenac; Double-Blind Method; Drug Combinations; Female; Humans; Male; M

1993
Review of the safety of diclofenac/misoprostol.
    Drugs, 1993, Volume: 45 Suppl 1

    Topics: Arthritis, Rheumatoid; Diclofenac; Drug Combinations; Humans; Misoprostol; Osteoarthritis; Safety; S

1993
The efficacy and tolerability of aceclofenac in the treatment of patients with ankylosing spondylitis: a multicenter controlled clinical trial. Aceclofenac Indomethacin Study Group.
    The Journal of rheumatology, 1996, Volume: 23, Issue:7

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Female; Humans; Ind

1996
Aceclofenac is as safe and effective as tenoxicam in the treatment of ankylosing spondylitis: a 3 month multicenter comparative trial. Spanish Study Group on Aceclofenac in Ankylosing Spondylitis.
    The Journal of rheumatology, 1996, Volume: 23, Issue:7

    Topics: Administration, Oral; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double

1996
Comparative responsiveness of 3 functional indices in ankylosing spondylitis.
    The Journal of rheumatology, 1999, Volume: 26, Issue:9

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Dose-Response Relationship, Drug; Drug A

1999
Evaluation of a German version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Dougados Functional Index (D-FI).
    Zeitschrift fur Rheumatologie, 1999, Volume: 58, Issue:4

    Topics: Activities of Daily Living; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cross-Cultural Com

1999
Tenoxicam compared with diclofenac in patients with ankylosing spondylitis.
    Current medical research and opinion, 1990, Volume: 11, Issue:10

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Consumer Behavior; Diclofenac; Female; Humans; Male;

1990
Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Drugs, 1988, Volume: 35, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Clinical Trials as Topic; Diclofenac; D

1988
Efficacy of diclofenac in ankylosing spondylitis.
    The American journal of medicine, 1986, Apr-28, Volume: 80, Issue:4B

    Topics: Adult; Aged; Clinical Trials as Topic; Diclofenac; Double-Blind Method; Female; Gastrointestinal Dis

1986
A double blind comparison of diclofenac and indomethacin in the treatment of ankylosing spondylitis.
    The Journal of rheumatology, 1987, Volume: 14, Issue:1

    Topics: Adult; Aged; Clinical Trials as Topic; Diclofenac; Double-Blind Method; Female; Humans; Indomethacin

1987
Diclofenac in the treatment of ankylosing spondylitis: review of worldwide clinical experience and report of a double-blind comparison with indomethacin.
    Seminars in arthritis and rheumatism, 1985, Volume: 15, Issue:2 Suppl 1

    Topics: Adolescent; Adult; Aged; Diclofenac; Double-Blind Method; Female; Humans; Indomethacin; Male; Middle

1985

Other Studies

17 other studies available for diclofenac and Spondylitis, Ankylosing

ArticleYear
[Whipple's disease with normal duodenal histology and ankylosing spondylitis].
    Deutsche medizinische Wochenschrift (1946), 2009, Volume: 134, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Ceftriaxone; Diagnosi

2009
M694V mutation may have a role in susceptibility to ankylosing spondylitis.
    Rheumatology international, 2009, Volume: 29, Issue:10

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Diclofenac; Drug Combinations; Female; F

2009
Cost effectiveness of etoricoxib versus celecoxib and non-selective NSAIDS in the treatment of ankylosing spondylitis.
    PharmacoEconomics, 2010, Volume: 28, Issue:4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Bayes Theorem; Celecoxib; Cost-Benefit Analysis; Cyclooxyge

2010
Assessment of the efficacy of pamidronate in ankylosing spondylitis: an open prospective trial.
    Singapore medical journal, 2010, Volume: 51, Issue:11

    Topics: Adolescent; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Blood Sediment

2010
Risk factors of adverse drug reaction from non-steroidal anti-inflammatory drugs in Shanghai patients with arthropathy.
    Acta pharmacologica Sinica, 2004, Volume: 25, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheu

2004
Nonsteroidal anti-inflammatory drug use in ankylosing spondylitis--a population-based survey.
    Clinical rheumatology, 2006, Volume: 25, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cohort Studies;

2006
A Friday afternoon case of apparent anti-glomerular basement nephritis.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:8

    Topics: Acetaminophen; Acute Kidney Injury; Analgesics; Animals; Anti-Glomerular Basement Membrane Disease;

2006
[Effective also in Bechterew disease].
    MMW Fortschritte der Medizin, 2007, Jun-21, Volume: 149, Issue:25-26

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Clinical Trials as Topic; Combined Modality Ther

2007
[Treatment of ankylosing spondylitis with slow-release diclofenac sodium in a single daily dose].
    Fortschritte der Medizin, 1982, Aug-05, Volume: 100, Issue:29

    Topics: Adult; Delayed-Action Preparations; Diclofenac; Female; Humans; Male; Phenylacetates; Spondylitis, A

1982
[Vitamin E in rheumatic disease therapy?].
    Zeitschrift fur Rheumatologie, 1998, Volume: 57, Issue:4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Arthritis, Rheumatoid; Diclofenac; Humans; Os

1998
Bacillus Calmette-Guérin associated arthropathy mimicking undifferentiated spondyloarthropathy.
    The Journal of rheumatology, 1999, Volume: 26, Issue:4

    Topics: Arthritis, Reactive; BCG Vaccine; Butanones; Carcinoma, Transitional Cell; Cytokines; Diagnosis, Dif

1999
Iatrogenic cost factors incorporating mild and moderate adverse events in the economic comparison of aceclofenac and other NSAIDs.
    PharmacoEconomics, 2001, Volume: 19, Issue:7

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diclofenac; Health Care Costs; Human

2001
Paravertebral abscess formation due to brucellosis in a patient with ankylosing spondylitis.
    Joint bone spine, 2001, Volume: 68, Issue:6

    Topics: Abscess; Adult; Anti-Bacterial Agents; Brucella; Brucellosis; Diclofenac; Doxycycline; Drug Therapy,

2001
[Diclofenac-Na in ankylosing spondylitis].
    Fortschritte der Medizin, 1977, Jul-14, Volume: 95, Issue:26

    Topics: Adult; Diclofenac; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Phenylacetates;

1977
[Fatal course of immune hemolytic anemia following administration of diclofenac].
    Beitrage zur Infusionstherapie = Contributions to infusion therapy, 1990, Volume: 26

    Topics: Anemia, Hemolytic, Autoimmune; Coombs Test; Diclofenac; Female; Hemoglobinometry; Humans; Injections

1990
A prospective nationwide cross-sectional study of NSAID usage in 1331 patients with ankylosing spondylitis.
    The Journal of rheumatology, 1990, Volume: 17, Issue:6

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cross-Sectional Studies; Diclofenac; F

1990
Changing the class of NSAID in cases of hepatotoxicity.
    Annals of the rheumatic diseases, 1988, Volume: 47, Issue:9

    Topics: Adult; Diclofenac; Humans; Ketoprofen; Liver; Male; Spondylitis, Ankylosing

1988